Literature DB >> 29669772

A case of H3N2 complicated by acute kidney injury secondary to rhabdomyolysis.

Sriram Gonakoti1, Janak Bahirwani1, Raja Naga Mahesh Maddala1, Sudha Vidyasagar1.   

Abstract

H3N2 was first detected in July 2011 in the USA. It is responsible for sporadic cases of influenza and localised outbreaks and has not yet taken over on an epidemic or pandemic scale. An 84-year-old man presented with a dry cough, fever and myalgia for 3 days. On examination, he had a pulse of 98 bpm and blood pressure of 124/88 mm Hg. The patient was tachypnoeic, SpO2 was 90%. Auscultation revealed bilateral diffuse wheeze and crackles. He had generalised muscle tenderness on examination. On admission, creatinine was 1.9 mg/dL and CK(creatine kinase) was 44 000 U/L. Chest X-ray was suggestive of ARDS (acute respiratory distress syndrome). Throat swab was positive for H3N2. The patient was given intravenous fluids, oral sodium bicarbonate, oxygen and oseltamivir tablet. In view of ARDS, he was given intravenous methylprednisolone and bronchodilators for bronchospasm. The patient improved symptomatically; vitals and lab reports were normal at the time of discharge. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  infectious diseases; influenza; respiratory medicine

Mesh:

Substances:

Year:  2018        PMID: 29669772      PMCID: PMC5911137          DOI: 10.1136/bcr-2018-224334

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  8 in total

1.  Rhabdomyolysis and Myoglobin-induced Acute Renal Failure.

Authors:  G H Malik
Journal:  Saudi J Kidney Dis Transpl       Date:  1998 Jul-Sep

2.  Exertional rhabdomyolysis after influenza A (H3N2) infection in a basketball player boy.

Authors:  E Sevketoglu; B Kural; A E Beskardes; S Hatipoglu
Journal:  Ann Trop Paediatr       Date:  2011

3.  Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices--United States, 2013-2014.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2013-09-20

4.  Severe rhabdomyolysis and acute renal failure following recent Coxsackie B virus infection.

Authors:  F Fodili; E F H van Bommel
Journal:  Neth J Med       Date:  2003-05       Impact factor: 1.422

5.  Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine.

Authors:  Paul E Marik; Stephen M Pastores; Djillali Annane; G Umberto Meduri; Charles L Sprung; Wiebke Arlt; Didier Keh; Josef Briegel; Albertus Beishuizen; Ioanna Dimopoulou; Stylianos Tsagarakis; Mervyn Singer; George P Chrousos; Gary Zaloga; Faran Bokhari; Michael Vogeser
Journal:  Crit Care Med       Date:  2008-06       Impact factor: 7.598

Review 6.  Bench-to-bedside review: Rhabdomyolysis -- an overview for clinicians.

Authors:  Ana L Huerta-Alardín; Joseph Varon; Paul E Marik
Journal:  Crit Care       Date:  2004-10-20       Impact factor: 9.097

Review 7.  Disseminated intravascular coagulation (DIC) and rhabdomyolysis in fulminant varicella infection--case report and review of the literature.

Authors:  U Hollenstein; F Thalhammer; H Burgmann
Journal:  Infection       Date:  1998 Sep-Oct       Impact factor: 7.455

8.  Exercise induced rhabdomyolysis with compartment syndrome and renal failure.

Authors:  Mary Colleen Bhalla; Ryan Dick-Perez
Journal:  Case Rep Emerg Med       Date:  2014-07-06
  8 in total
  1 in total

1.  Effect of Influenza Vaccination on the Reduction of the Incidence of Chronic Kidney Disease and Dialysis in Patients with Type 2 Diabetes Mellitus.

Authors:  Li-Chin Sung; Chun-Chao Chen; Shih-Hao Liu; Chun-Chih Chiu; Tsung-Yeh Yang; Cheng-Hsin Lin; Yu-Ann Fan; William Jian; Meng-Huan Lei; Hsien-Tang Yeh; Min-Huei Hsu; Wen-Rui Hao; Ju-Chi Liu
Journal:  J Clin Med       Date:  2022-08-03       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.